Shopping Cart
Remove All
Your shopping cart is currently empty
TRX-518 is a humanized agonist antibody targeting the glucocorticoid-induced tumor necrosis factor receptor (GITR). It specifically targets GITR⁺ regulatory T cells (Tregs) and CD45RA⁻Foxp3⁺ effector Tregs (eTregs) within regulatory T cells, effectively reducing the number of Tregs in circulation and within tumors.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | TRX-518 is a humanized agonist antibody targeting the glucocorticoid-induced tumor necrosis factor receptor (GITR). It specifically targets GITR⁺ regulatory T cells (Tregs) and CD45RA⁻Foxp3⁺ effector Tregs (eTregs) within regulatory T cells, effectively reducing the number of Tregs in circulation and within tumors. |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Target | GITR |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.